Literature DB >> 15304028

The effect of anticoagulant drugs on cancer.

A Falanga1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15304028     DOI: 10.1111/j.1538-7836.2004.00868.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  6 in total

1.  The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods.

Authors:  Sarah B Frazier; Kevin A Roodhouse; Dennis E Hourcade; Lijuan Zhang
Journal:  Open Glycosci       Date:  2008-01-01

Review 2.  Platelets and metastasis revisited: a novel fatty link.

Authors:  Gaorav P Gupta; Joan Massagué
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

Review 3.  Heparin: 100 years of pleiotropic effects.

Authors:  Adilson Ferraz Paschoa
Journal:  J Thromb Thrombolysis       Date:  2016-05       Impact factor: 2.300

4.  The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

Authors:  Ahmed Boucharaba; Claire-Marie Serre; Julien Guglielmi; Jean-Claude Bordet; Philippe Clézardin; Olivier Peyruchaud
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-12       Impact factor: 11.205

5.  Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts.

Authors:  Michael Samoszuk; Emi Kanakubo; John K Chan
Journal:  BMC Cancer       Date:  2005-09-21       Impact factor: 4.430

6.  Comparative assessment of low-molecular-weight heparins in cancer from the perspective of patient outcomes and survival.

Authors:  Anna Falanga; Alfonso Vignoli; Erika Diani; Marina Marchetti
Journal:  Patient Relat Outcome Meas       Date:  2011-11-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.